Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.520
-0.070 (-4.40%)
Nov 21, 2024, 4:00 PM EST - Market closed
Atai Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 255 | 234 | 441 | 1,223 | - | - |
| Market Cap Growth | -9.11% | -46.95% | -63.92% | - | - | - |
| Enterprise Value | 205 | 46 | 161 | 806 | - | - |
| Last Close Price | 1.59 | 1.41 | 2.66 | 7.63 | - | - |
| PS Ratio | 588.06 | 745.46 | 1893.68 | 60.03 | - | - |
| PB Ratio | 1.75 | 0.96 | 1.66 | 3.17 | - | - |
| P/TBV Ratio | 1.34 | 0.96 | 1.69 | 3.25 | - | - |
| EV/Sales Ratio | 620.19 | 147.41 | 690.79 | 39.54 | - | - |
| Debt / Equity Ratio | 0.16 | 0.09 | 0.07 | 0.01 | 0.02 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.08 | - | - |
| Quick Ratio | 4.37 | 9.00 | 14.01 | 17.56 | 7.99 | 18.99 |
| Current Ratio | 5.81 | 9.22 | 14.43 | 17.92 | 8.09 | 24.36 |
| Return on Equity (ROE) | -62.77% | -17.21% | -48.31% | -72.40% | -230.26% | - |
| Return on Assets (ROA) | -25.41% | -25.52% | -25.09% | -28.61% | -66.32% | - |
| Return on Capital (ROIC) | -28.08% | -27.82% | -26.84% | -30.91% | -73.14% | - |
| Earnings Yield | -50.26% | -17.18% | -34.54% | -13.72% | - | - |
| FCF Yield | -36.05% | -23.85% | -5.27% | - | - |
| Buyback Yield / Dilution | -3.48% | -2.00% | -12.62% | -48.64% | -973.40% | - |
| Total Shareholder Return | -3.48% | -2.00% | -12.62% | -48.64% | -973.40% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.